Potential new therapeutic targets for Schistosomiasis
Nature Communications
August 10, 2011
Modification of the DNA of the parasitic flatworm Schistosoma mansoni that gives rise to the disease Schistomiasis is identified in Nature Communications. The finding could potentially be used to identify targets to control these pathogens which cause one of the world’s most prevalent parasitic diseases.
Schistomiasis is a chronic and debilitating disease caused by blood flukes. Karl Hoffmann and colleagues show for the first time that the genomic DNA of the blood fluke Schistosoma mansoni is methylated and they also identify proteins that are likely to mediate this modification of the DNA. They found that chemical inhibition of these proteins with the FDA approved chemotherapeutic drug 5-azacytidine, reduced methylation and also reduced the egg production of female blood flukes and caused morphological abnormalities of the remaining eggs.
These findings suggest that targeting the proteins that methylate the DNA of the flood fluke could be used in their control.
doi: 10.1038/ncomms1433
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature